McGregor S Elizabeth, Hilsden Robert J, Murray Alison, Bryant Heather E
Division of Population Health and Information, Alberta Cancer Board, Calgary, Alberta, Canada T2N 4N2.
Prev Med. 2004 Aug;39(2):279-85. doi: 10.1016/j.ypmed.2004.03.037.
The Canadian Task Force on Preventive Health Care (CTFPHC), in 2001, concluded that there is good evidence to include annual or biennial fecal occult blood testing (FOBT) and fair evidence to include flexible sigmoidoscopy in the periodic health examination of asymptomatic adults more than 50 years of age.
Mailed survey of Alberta primary care physicians to determine current colorectal cancer (CRC) screening practices, familiarity with the new guideline, and opinions about, and barriers to, screening average-risk patients.
Response rate was 58.0% (n = 965). Less than half (41.9%) were familiar with the new Canadian guideline. The majority (74.7%) recommended that asymptomatic patients undergo screening; however, only 35.6% offered screening to at least 75% of average-risk patients. Few (9.4%) rated fecal occult blood as an "excellent or very good" screening test. Most (64.1%) physicians would choose colonoscopy if they themselves were to undergo screening. Concerns were raised about cost-effectiveness, inconsistencies of current recommendations, and resources.
Although supportive of colorectal cancer screening of average-risk patients, few physicians recommend screening for the majority of their patients. Clarification of inconsistencies between guidelines, resource issues, and the availability of efficacious screening tests is required for wider acceptance of the new Canadian guideline.
加拿大预防性医疗保健特别工作组(CTFPHC)在2001年得出结论,有充分证据表明在50岁以上无症状成年人的定期健康检查中应包括每年或每两年进行一次粪便潜血检测(FOBT),有合理证据表明应包括乙状结肠镜检查。
对艾伯塔省的初级保健医生进行邮寄调查,以确定当前的结直肠癌(CRC)筛查做法、对新指南的熟悉程度以及对筛查平均风险患者的看法和障碍。
回复率为58.0%(n = 965)。不到一半(41.9%)的人熟悉新的加拿大指南。大多数人(74.7%)建议无症状患者接受筛查;然而,只有35.6%的人对至少75%的平均风险患者进行了筛查。很少有人(9.4%)将粪便潜血评为“优秀或非常好”的筛查测试。大多数医生(64.1%)表示,如果他们自己要接受筛查,会选择结肠镜检查。人们对成本效益、当前建议的不一致性和资源问题表示担忧。
尽管支持对平均风险患者进行结直肠癌筛查,但很少有医生建议对大多数患者进行筛查。为了更广泛地接受新的加拿大指南,需要澄清指南之间的不一致性、资源问题以及有效筛查测试的可用性。